Ms. Pomrehn has more than 20 years of experience in investor relations, corporate communications and sustainability across various industries, including healthcare, finance and chemicals, according to a Nov. 21 news release sent to Becker’s.
She has worked in senior leadership roles for companies including MorphoSys, Clariant and UBS, leading investor relations, crisis communication, capital markets, mergers and acquisitions, and environmental governance.
She will report directly to Medacta’s CEO, Francesco Siccardi.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
